Will Stone

The company tells NPR it's being required to repeat the studies in the U.S.

before seeking approval from regulators here.

Richard Price, a spine surgeon at UC Davis, says many of his patients ask about using cannabis.

Because cannabis is a Schedule I drug, running large research trials comes with many obstacles, meaning it will likely be years before that additional research gets completed.

Will Stone, NPR News.

Earlier this week, the city of Long Beach reported the first case.

Then, two more turned up in Los Angeles County, which has a separate health department.

All three people were hospitalized and are now recovering.

It's not clear how they caught this type of mpox, known as Clade 1, which is different from the strain that surged in the U.S.

in 2022.

This version of the virus has fueled outbreaks in parts of Africa, in particular the Democratic Republic of the Congo, DRC, and other nearby countries.

Public health officials say they are investigating the cases, and at this point, there's no clear link between them.

Mpox tends to cause rashes or unusual sores, fever, and other flu-like symptoms.

Will Stone, NPR News.

Federal health officials were going to consider two different reports on alcohol.

One of them, from the National Academies of Sciences, Engineering, and Medicine, found moderate drinking was associated with a lower risk of dying, including from cardiovascular disease.

The other study essentially came to the opposite conclusion, that even low levels of drinking increase your risk of dying for many causes, including cancer and stroke.

Scientists who worked on that report were told recently it would not be considered as part of the new guidelines.

Mike Marshall is with the U.S.

Alcohol Policy Alliance.